PacBio enables rare and inherited disease research by adding tertiary analysis partners to PacBio Compatible Post author: Post published:November 1, 2023 Post category:uncategorized Partnerships maximize value of HiFi data and complete the full end-to-end workflow for PacBio customers. You Might Also Like Study uncovers how certain E. coli bacteria in the gut promote colon cancer November 6, 2024 Transformative $8 million donation fuels pancreatic cancer research at WEHI An Exceptional $8 Million, 10… May 21, 2024 CARMAT’s Aeson device gains momentum in Europe as a bridge-to-transplant solution November 18, 2024
Transformative $8 million donation fuels pancreatic cancer research at WEHI An Exceptional $8 Million, 10… May 21, 2024